EUVIMEDEUVIMED entdecken
Crossref

Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis

Doruk Arslan, Zeynep Ergul-Ulger, Sibel Goksen, Gunes Esendagli, Sevim Erdem-Ozdamar, Ersin Tan, Can Ebru Bekircan-Kurt

European Neurology · 2024

DOI: 10.1159/000540794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Neurology, 2024. Verfasst von Doruk Arslan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hacettepe University School of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Myasthenia Gravis, Th17 Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Contribution of T helper 1 and 2 cells-related cytokines to pathogenesis of myasthenia gravis (MG) is well known. Recently, the contribution of follicular T helper (Tfh) and T helper 17 cells-related molecules to the pathogenesis has gained importance. In this study, we aimed to evaluate the changes in Tfh- and Th17-related molecules before and after rescue therapy in patients with myasthenic crisis (cMG) and to reveal the molecular differences between stable MG and cMG patients.

Methods

Patients with stable generalized MG (gMG) and cMG were classified according to Myasthenia Gravis Foundation of America (MGFA) classification. Serum samples were collected from cMG patients both before and after rescue therapy (plasmapheresis or intravenous immunoglobulin [IVIg]). Serum levels of Tfh- and selected Th17-related molecules (IL-22, IL-17A, CXCL13, sPD-L1, sICOSLG, and sCD40L) were analyzed by commercial ELISA kits.

Results

Twelve cMG (6 for IVIg, 6 for plasmapheresis) and 10 gMG patients were included in the study. A decrease in serum sPD-L1 and CXCL13 levels was observed in cMG patients after treatment, regardless of the treatment modality (p < 0.05). In contrast, serum sICOSLG levels decreased only in patients treated with IVIg (p < 0.05) and serum IL-22 levels increased in patients receiving plasmapheresis (p < 0.05). cMG patients had higher serum IL-17A levels compared to stable patients (p < 0.001) and its level was positively correlated with disease severity (r = 0.678, p = 0.001).

Conclusion

Our results confirm the contribution of Tfh- and Th17-related cell pathways to MG pathogenesis. Both IVIg and plasmapheresis appear to be effective in reducing Tfh- and Th17-related cytokine/molecule levels in cMG patients. Increased serum IL-17A levels may contribute to disease severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisTh17 CellsHumansFemaleMaleMiddle AgedAdultImmunoglobulins, IntravenousSeverity of Illness IndexAgedPlasmapheresisT Follicular Helper CellsCytokines

Stichwörter der Autor:innen

Follicular T helper cellsMyasthenia gravisMyasthenic crisisRescue treatmentsT helper 17 cells

Substanzen

Immunoglobulins, IntravenousCytokines

Autor:innen und Institutionen

  • Department of Neurology, Hacettepe University School of Medicine, Ankara, Turkey.
  • Department of Neurology, Sincan Research and Training Hospital, Ankara, Turkey.
  • Department of Medical and Surgical Research, Hacettepe University Institute of Health Sciences, Ankara, Turkey.
  • Department of Basic Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Neuromuscular Diseases and Research Laboratory, Department of Neurology, Hacettepe University School of Medicine, Ankara, Turkey.

Zitieren

APA

Arslan, D., Ergul-Ulger, Z., Goksen, S., Esendagli, G., Erdem-Ozdamar, S., Tan, E., & Bekircan-Kurt, C. E. (2024). Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis. European Neurology. https://doi.org/10.1159/000540794

Vancouver

Arslan D, Ergul-Ulger Z, Goksen S, Esendagli G, Erdem-Ozdamar S, Tan E, et al. Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis. European Neurology. 2024. doi:10.1159/000540794

BibTeX
@article{Arslan2024,
  author = {Arslan, Doruk and Ergul-Ulger, Zeynep and Goksen, Sibel and Esendagli, Gunes and Erdem-Ozdamar, Sevim and Tan, Ersin and Bekircan-Kurt, Can Ebru},
  title = {Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis},
  journal = {European Neurology},
  year = {2024},
  doi = {10.1159/000540794}
}
Kostenlos starten →